BriaCell Therapeutics

BCTX51

Penny Stock

$0.72arrow_drop_down6.84%-$0.05

Penny Stock

BCTX51

$0.72

arrow_drop_down6.84%-$0.05

Penny Stock

Performance History

Key Stats
Open	$0.61
Prev. Close	$0.60
EPS	-0.29
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$28.54M
PE Ratio	-

	LOW	HIGH
Day Range	0.60	0.80
52 Week Range	0.46	6.10

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.29

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About BriaCell Therapeutics (BCTX)

BriaCell Therapeutics Corp. (BCTX) is a clinical-stage biotechnology company focused on developing innovative immunotherapies for the treatment of cancer. The company's lead product candidate, Bria-IMT, is a personalized immunotherapy that is being evaluated in clinical trials for the treatment of advanced breast cancer. Bria-IMT works by stimulating the patient's immune system to recognize and target cancer cells, potentially leading to improved outcomes and reduced side effects compared to traditional cancer treatments.

BCTX stock has a history of volatility, with the price fluctuating significantly over the years. Investors should be aware that the stock's performance can be affected by various factors, including clinical trial results, regulatory approvals, and market conditions. It is important to conduct thorough research and analysis before making any investment decisions.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. William V. Williams M.D.
Headquarters: West Vancouver
Employees: 0
Exchange: NASDAQ

Keep an eye on BriaCell Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is BriaCell Therapeutics's (BCTX) price per share?

The current price per share for BriaCell Therapeutics (BCTX) is $0.73. The stock has seen a price change of -$0.05 recently, indicating a -6.84% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for BriaCell Therapeutics (BCTX)?

For BriaCell Therapeutics (BCTX), the 52-week high is $6.1, which is 735.96% from the current price. The 52-week low is $0.46, the current price is 58.63% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is BriaCell Therapeutics (BCTX) a growth stock?

BriaCell Therapeutics (BCTX) has shown an average price growth of -6.03% over the past three years. It has received a score of 5 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying BriaCell Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is BriaCell Therapeutics (BCTX) stock price performance year to date (YTD)?

As of the latest data, BriaCell Therapeutics (BCTX) has a year-to-date price change of -86.34%. Over the past month, the stock has experienced a price change of -8.35%. Over the last three months, the change has been -2.71%. Over the past six months, the figure is -51.03%.

help

Is BriaCell Therapeutics (BCTX) a profitable company?

BriaCell Therapeutics (BCTX) has a net income of -$4.93M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$32.81M. Furthermore, the EBITDA is -$33.25M.

help

What is the market capitalization of BriaCell Therapeutics (BCTX)?

BriaCell Therapeutics (BCTX) has a market capitalization of $26.4M. The average daily trading volume is 0.74, indicating the stock's liquidity and investor engagement.